X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-full-year-2023-financial-results-and-provides-business-update-302095695.html
https://www.prnewswire.com/news-releases/hanall-biopharma-daewoong-pharmaceutical-and-nurron-pharmaceuticals-to-showcase-ongoing-parkinsons-disease-program-at-the-7th-annual-sachs-associates-neuroscience-innovation-forum-302019893.html
https://www.prnewswire.com/news-releases/hanall-biopharmas-partner-nurron-pharmaceuticals-incorporated-appoints-dr-almira-chabi-md-egmp-to-board-of-directors-302010850.html
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-third-quarter-2023-financial-results-and-provides-a-business-update-301968423.html
https://www.prnewswire.com/news-releases/hanall-biopharma-daewoong-pharmaceutical-and-nurron-pharmaceuticals-initiate-first-in-human-phase-1-clinical-study-of-hl192-301954586.html
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-second-quarter-2023-financial-results-and-provides-a-business-update-301887101.html
https://www.prnewswire.com/news-releases/hanall-biopharma-and-daewoong-pharmaceutical-co-invest-in-vincere-biosciences-for-collaborative-opportunities-in-parkinsons-disease-301848025.html
https://www.prnewswire.com/news-releases/hanall-biopharma-announces-results-from-phase-iii-randomized-double-masked-active-treatment-controlled-velos-3-trial-evaluating-tanfanercept-0-25-for-treatment-of-dry-eye-disease-301829433.html
https://www.prnewswire.com/news-releases/hanall-biopharma-assigns-su-jin-park-as-co-ceo-to-drive-next-phase-of-growth-301784292.html
https://www.prnewswire.com/news-releases/hanall-biopharma-opens-applications-for-the-2023-pharmaceutical-industry-fellowship-program-301772737.html
Market Place
Share 
